India's Pharmaceutical Exports

Country Profile

Singapore

Singapore is a significant market for Indian pharmaceutical exports — $126M in FY 2025–26. Medicines accounts for 54% of shipments, with vaccines contributing $2.05M. The compound annual growth rate since FY2015 stands at 3.3%.

🇸🇬 $126M · 1.4× growth since FY2015 · 3.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$126M
Exports FY2025–26 DGCIS
1.4×
Growth FY2015→2026
3.3%
CAGR FY2015→2026
54%
Medicines Share
5
Product Categories Supplied
Singapore is a significant market for Indian pharmaceutical exports — $126M in FY 2025–26. Medicines accounts for 54% of shipments, with vaccines contributing $2.05M. The compound annual growth rate since FY2015 stands at 3.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $67.6M (53.6%) Medicine Ingredients $47.7M (37.8%) Surgical & Hospital Supplies $5.98M (4.7%) Traditional & Herbal $2.81M (2.2%) Vaccines $2.05M (1.6%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Singapore in the RBI overseas direct investment dataset (2011–2026).